Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 09/06/2024 at 16:05, 1 year 2 months ago

Jaguar Health fera une présentation à la conférence annuelle sur les investissements mondiaux organisée par HC Wainwright du 9 au 11 septembre

Lisa Conte Médicaments Santé Jaguar Présentation Virtuelle Conférence HC Wainwright
PRESS RELEASE

published on 09/06/2024 at 16:00, 1 year 2 months ago

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
Jaguar Health, Inc. (NASDAQ:JAGX) founder Lisa Conte to present virtually at H.C. Wainwright Global Investment Conference. Focus on plant-derived medicines for gastrointestinal distress

Gastrointestinal Distress Jaguar Health Lisa Conte H.C. Wainwright Plant-derived Medicines
BRIEF

published on 09/05/2024 at 14:35, 1 year 3 months ago

Jaguar Health Celebrates National Service Dog Month Highlighting Its Cancer Care Drugs

Cancer Care FDA Approval Jaguar Health Canalevia-CA1 Service Dogs
BRIEF

published on 09/05/2024 at 14:35, 1 year 3 months ago

Jaguar Health célèbre le mois national des chiens d'assistance en mettant en avant ses médicaments contre le cancer

Canalevia-CA1 Soins Contre Le Cancer Approbation De La FDA Santé Jaguar Chiens D'assistance
PRESS RELEASE

published on 09/05/2024 at 14:30, 1 year 3 months ago

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Jaguar Health's Canalevia-CA1 drug receives FDA conditional approval for chemotherapy-induced diarrhea treatment in dogs, making it the first approved treatment for this condition

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Dogs
BRIEF

published on 09/04/2024 at 16:05, 1 year 3 months ago

Jaguar Health Announces Key Commercial and Development Milestones

Crofelemer Clinical Trials Jaguar Health Rare Diseases Gelclair®
BRIEF

published on 09/04/2024 at 16:05, 1 year 3 months ago

Jaguar Health annonce des étapes clés en matière de développement et de commercialisation

Crofelemer Essais Cliniques Maladies Rares Santé Jaguar Gelclair®
PRESS RELEASE

published on 09/04/2024 at 16:00, 1 year 3 months ago

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details

Jaguar Health Inc. Rare Diseases Gelclair Launch Crofelemer Trials Lisa Conte Interview
BRIEF

published on 08/27/2024 at 16:05, 1 year 3 months ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

Crofelemer Short Bowel Syndrome Patent Jaguar Health Intellectual Property
BRIEF

published on 08/27/2024 at 16:05, 1 year 3 months ago

Un brevet délivré en Jordanie renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement du syndrome de l'intestin court (SIC)

Crofelemer Propriété Intellectuelle Brevet Santé Jaguar Syndrome De L'intestin Court

Accesswire

Published on 12/06/2025 at 02:00, 6 hours 32 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 7 hours 17 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 8 hours 7 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 8 hours 32 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 9 hours 2 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 10 hours 16 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 10 hours 20 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 13 hours 34 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 14 hours 6 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 14 hours 17 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 9 hours 32 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 9 hours 32 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 9 hours 32 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 9 hours 32 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 15 hours 14 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE